Propanc Biopharma (PPCB) Liabilities and Shareholders Equity (2011 - 2026)
Propanc Biopharma (PPCB) posted Liabilities and Shareholders Equity of $12.78 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 34.9% from $19.63 million a year earlier.
Powered by 
Analysis
Propanc Biopharma (PPCB) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends
Since fiscal Q4 2011, Propanc Biopharma has reported Liabilities and Shareholders Equity for 56 quarters.
- Annual Liabilities and Shareholders Equity shows a five-year compound annual growth rate of 296.1% (FY2021 to FY2026).
- In prior fiscal years, Propanc Biopharma's Liabilities and Shareholders Equity was $19.63 million in FY2025, $72,365 in FY2024 (+20.0%), $60,328 in FY2023 (-26.1%) and $81,651 in FY2022 (+523.2%).
- The fiscal Q4 2026 figure stands as the lowest quarterly Liabilities and Shareholders Equity since fiscal Q2 2025.
- The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was fiscal Q4 2022, with growth of 523.2%; the weakest was fiscal Q3 2024, with a decline of 74.0%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Propanc Biopharma | 550,617.42 | 550,617.42 | - | 12.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.78 Mn |
| Dec 31, 2025 | 15.11 Mn |
| Sep 30, 2025 | 17.98 Mn |
| Jun 30, 2025 | 19.63 Mn |
| Mar 31, 2025 | 22.53 Mn |
| Dec 31, 2024 | 78,533.00 |
| Sep 30, 2024 | 63,644.00 |
| Jun 30, 2024 | 72,365.00 |
| Mar 31, 2024 | 37,337.00 |
| Dec 31, 2023 | 241,907.00 |
| Sep 30, 2023 | 180,371.00 |
| Jun 30, 2023 | 60,328.00 |
| Mar 31, 2023 | 143,742.00 |
| Dec 31, 2022 | 108,022.00 |
| Sep 30, 2022 | 94,254.00 |
| Jun 30, 2022 | 81,651.00 |
| Mar 31, 2022 | 169,460.00 |
| Dec 31, 2021 | 110,177.00 |
| Sep 30, 2021 | 62,165.00 |
| Jun 30, 2021 | 13,101.00 |
API Access
Propanc Biopharma Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=PPCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "PPCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=PPCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();